023910 — Dai Han Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Annual cashflow statement for Dai Han Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	22,670	24,961	28,426	33,759	27,644
Depreciation
Amortisation
Non-Cash Items	10,392	11,572	12,241	9,597	9,788
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-3,856	-16,740	-10,471	-14,995	-21,048
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	40,617	28,999	38,860	35,643	25,604
Capital Expenditures	-11,850	-8,621	-21,280	-15,801	-25,123
Purchase of Fixed Assets
Other Investing Cash Flow Items	336	8,815	3,283	-56,824	-12,489
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-11,515	193	-17,998	-72,626	-37,612
Financing Cash Flow Items	-61.7	—	-80	0	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-7,408	-22,543	-10,332	-4,368	-5,232
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	22,367	7,092	10,644	-40,199	-17,329